A Phase I Study of a Personalized NeoAntigen Cancer Vaccine with Radiotherapy Plus Pembrolizumab/ MK-3475 Among Newly Diagnosed Glioblastoma Patients
ENROLLING
Trial ID:
NCT02287428 Protocol # :
14-362
Phase
I
Disease Sites
Brain and Nervous System
Principal Investigator
Reardon, David, A.
Site Investigator
Reardon, David, A.
Site Research Nurses
Aspinwall, Sheridan
Donohoe, Aisling
KANE, CAROLINE
Lafrankie, Debra
Ruland, Sandra, French
Thistle, Katrina, M.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #14-362
14-362